The Europe Vitamin K2 Market would witness market growth of 12.9% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $17.31 millions by 2031, growing at a CAGR of 11.6 % during the forecast period. The UK market is expected to witness a CAGR of 12% during (2024 - 2031). Additionally, The France market is expected to witness a CAGR of 13.8% during (2024 - 2031).
Vitamin K2's role in activating proteins that regulate calcium deposition underscores its importance in maintaining optimal health. There is a protein known as osteocalcin that plays a significant role in the process of binding calcium to the bone matrix, which in turn helps to enhance bone mineralization and strength.
Moreover, another protein, matrix Gla-protein (MGP), inhibits calcium from depositing in the arteries, preventing arterial calcification and promoting cardiovascular health. These dual functions of vitamin K2 in bone and cardiovascular health drive its demand as an essential dietary supplement.
Europe has a growing aging population, which is more susceptible to conditions like osteoporosis and cardiovascular disease. Vitamin K2 shows promise in preventing and managing these conditions, making it attractive for this demographic. The Federal Statistical Office of Germany (Destatis) predicts that the number of individuals in Germany who are at least 67 years of age will increase by approximately 4 million to a minimum of 20.0 million by the mid-2030s. The number of people who are 80 years old or older is expected to stay relatively consistent until the middle of the 2030s, with a range of 5.8 to 6.7 million.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $17.31 millions by 2031, growing at a CAGR of 11.6 % during the forecast period. The UK market is expected to witness a CAGR of 12% during (2024 - 2031). Additionally, The France market is expected to witness a CAGR of 13.8% during (2024 - 2031).
Vitamin K2's role in activating proteins that regulate calcium deposition underscores its importance in maintaining optimal health. There is a protein known as osteocalcin that plays a significant role in the process of binding calcium to the bone matrix, which in turn helps to enhance bone mineralization and strength.
Moreover, another protein, matrix Gla-protein (MGP), inhibits calcium from depositing in the arteries, preventing arterial calcification and promoting cardiovascular health. These dual functions of vitamin K2 in bone and cardiovascular health drive its demand as an essential dietary supplement.
Europe has a growing aging population, which is more susceptible to conditions like osteoporosis and cardiovascular disease. Vitamin K2 shows promise in preventing and managing these conditions, making it attractive for this demographic. The Federal Statistical Office of Germany (Destatis) predicts that the number of individuals in Germany who are at least 67 years of age will increase by approximately 4 million to a minimum of 20.0 million by the mid-2030s. The number of people who are 80 years old or older is expected to stay relatively consistent until the middle of the 2030s, with a range of 5.8 to 6.7 million.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Market Report Segmentation
By Product Type- MK-7
- MK-4
- Powder & Crystalline
- Capsules & Tablets
- Oils & Liquid
- Health Supplements
- Pharmaceutical
- Functional Food & Beverages
- Natural
- Synthetic
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Vitamin K2 Market by Product Type
Chapter 5. Europe Vitamin K2 Market by Form
Chapter 6. Europe Vitamin K2 Market by Application
Chapter 7. Europe Vitamin K2 Market by Source
Chapter 8. Europe Vitamin K2 Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Methodology
LOADING...
